Peer-reviewedCC BY 4.0International Journal of Molecular Sciences
Special Issue “Molecular Mechanisms and Therapies of Pancreatic Cancer: 2nd Edition”
- 1Institute of Genetics and Biophysics ‘Adriano Buzzati-Traverso’ (IGB), CNR, 80131 Naples, Italy
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is the predominant histological form of pancreatic cancer and remains one of the most aggressive and therapeutically challenging malignancies [...]
Related
- Stem Cell-Based Therapies in Companion Animals: Molecular Mechanisms, Clinical Applications, and Translational Perspectives
- Ketogenic Dietary Therapies and β-Hydroxybutyrate as Modulators of Mitochondrial Function: From Molecular Mechanisms to Clinical Translation
- Beyond Weight Loss and Glycemic Control: Molecular Mechanisms and Hypothesis-Generating Therapeutic Potential of Incretin-Based Therapies Against Peritoneal Fibrosis in Peritoneal Dialysis.
- Molecular mechanisms by which the intratumoral microbiome drives pancreatic ductal adenocarcinoma progression and therapeutic response
- Biliary and Pancreatic Safety of Incretin-Based Therapies in Obesity and Type 2 Diabetes: A Propensity-Matched Real-World Comparison of Tirzepatide, Semaglutide, and DPP-4 Inhibitors
BibTeX
@article{vilardo2026special,
title = {{Special Issue “Molecular Mechanisms and Therapies of Pancreatic Cancer: 2nd Edition”}},
author = {Claudia Vilardo and Annalisa Di Domenico and Donatella Delle Cave},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = sep,
doi = {10.3390/ijms27198735},
url = {https://www.mdpi.com/1422-0067/27/19/8735},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Special Issue “Molecular Mechanisms and Therapies of Pancreatic Cancer: 2nd Edition”
AU - Claudia Vilardo
AU - Annalisa Di Domenico
AU - Donatella Delle Cave
PY - 2026
DA - 2026/09/30
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27198735
UR - https://www.mdpi.com/1422-0067/27/19/8735
AB - Pancreatic ductal adenocarcinoma (PDAC) is the predominant histological form of pancreatic cancer and remains one of the most aggressive and therapeutically challenging malignancies [...]
SN - 1422-0067
ER -